120 related articles for article (PubMed ID: 17929441)
1. [Molecular physiopathology of Sjogren's syndrome and its therapeutic strategy].
Sumida T
Nihon Naika Gakkai Zasshi; 2007 Sep; 96(9):1967-73. PubMed ID: 17929441
[No Abstract] [Full Text] [Related]
2. T cells and the loss of immunologic tolerance in Sjögren's syndrome and systemic lupus erythematosus.
Hoffman RW
Arthritis Rheum; 2007 Oct; 56(10):3180-2. PubMed ID: 17907162
[No Abstract] [Full Text] [Related]
3. Regulatory T cell epitope recognized by T cells from labial salivary glands of patients with Sjögren's syndrome.
Sumida T; Kato T; Hasunuma T; Maeda T; Nishioka K; Matsumoto I
Arthritis Rheum; 1997 Dec; 40(12):2271-3. PubMed ID: 9416868
[No Abstract] [Full Text] [Related]
4. Novel fragments of the Sjögren's syndrome autoantigens alpha-fodrin and type 3 muscarinic acetylcholine receptor generated during cytotoxic lymphocyte granule-induced cell death.
Nagaraju K; Cox A; Casciola-Rosen L; Rosen A
Arthritis Rheum; 2001 Oct; 44(10):2376-86. PubMed ID: 11665980
[TBL] [Abstract][Full Text] [Related]
5. [Molecular mechanism in Sjögren syndrome: T cell receptors and autoantigens].
Sumida T
Ryumachi; 2002 Oct; 42(5):769-76. PubMed ID: 12465594
[No Abstract] [Full Text] [Related]
6. Sjogren's syndrome.
Sumida T
Intern Med; 1999 Feb; 38(2):165-8. PubMed ID: 10225675
[No Abstract] [Full Text] [Related]
7. Immunopathogenesis of Sjögren's syndrome.
Moutsopoulos HM
Isr J Med Sci; 1988 Dec; 24(12):737-9. PubMed ID: 3066783
[No Abstract] [Full Text] [Related]
8. [What common grounds exist in the pathomechanism of Sjögren disease and associated hematologic diseases? From autoreactive B cell activation and T cell cooperation to B-cell lymphoma. Pathogenesis of lymphoproliferations in patients with Sjögren syndrome].
Wagner U; Seidel W; Häntzschel H
Z Rheumatol; 2002 Apr; 61(2):209-11. PubMed ID: 12056302
[No Abstract] [Full Text] [Related]
9. [Sjogren's syndrome--molecular mechanism of the etiology and the specific regulatory therapy].
Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 1999 Jun; 22(3):101-10. PubMed ID: 11126661
[No Abstract] [Full Text] [Related]
10. Muscarinic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome.
Naito Y; Matsumoto I; Wakamatsu E; Goto D; Sugiyama T; Matsumura R; Ito S; Tsutsumi A; Sumida T
Ann Rheum Dis; 2005 Mar; 64(3):510-1. PubMed ID: 15708912
[No Abstract] [Full Text] [Related]
11. Primary Sjögren's syndrome and deficiency of ICA69.
Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
[TBL] [Abstract][Full Text] [Related]
12. Comparison in T- and B-cell markers in patients with Sjögren's syndrome and systemic lupus erythematosus.
Morimoto C; Reinherz EL; Nadler LM; Distaso JA; Steinberg AD; Schlossman SF
Clin Immunol Immunopathol; 1982 Feb; 22(2):270-8. PubMed ID: 6213332
[No Abstract] [Full Text] [Related]
13. Autoantigen
Hillen MR; Urso K; Koppe E; Lopes AP; Blokland SLM; Pandit A; Slocombe T; van Maurik A; van Roon JAG; Radstake TRDJ
RMD Open; 2020 Jun; 6(2):. PubMed ID: 32540951
[No Abstract] [Full Text] [Related]
14. Antimuscarinic antibodies in Sjögren's syndrome: where are we, and where are we going?
Dawson L; Tobin A; Smith P; Gordon T
Arthritis Rheum; 2005 Oct; 52(10):2984-95. PubMed ID: 16200578
[No Abstract] [Full Text] [Related]
15. Latest update on the primary Sjögren's syndrome.
Youinou P; Pers JO
Presse Med; 2012 Sep; 41(9 Pt 2):e437-9. PubMed ID: 22857888
[No Abstract] [Full Text] [Related]
16. [Physiopathology of autoimmune diseases--recent findings. 1) Unique mechanism associated with Sjogren's syndrome].
Sumida T
Nihon Naika Gakkai Zasshi; 1998 Sep; 87(9):1717-23. PubMed ID: 9816837
[No Abstract] [Full Text] [Related]
17. Hypothesis for autoantigen presentation and T cell activation.
Mircheff AK; Gierow JP; Wood RL; Akashi RH; Hofman FM
Adv Exp Med Biol; 1994; 350():651-4. PubMed ID: 8030550
[No Abstract] [Full Text] [Related]
18. [T and B cells and ADCC (antibody-dependent cell-mediated cytotoxicity) in Sjogren's disease].
Arimori S; Ichikawa Y; Takaya M
Nihon Rinsho; 1983; 41(2):446-9. PubMed ID: 6602896
[No Abstract] [Full Text] [Related]
19. Pathogenic role of anti-M3 muscarinic acetylcholine receptor immune response in Sjögren's syndrome.
Sumida T; Iizuka M; Asashima H; Tsuboi H; Matsumoto I
Presse Med; 2012 Sep; 41(9 Pt 2):e461-6. PubMed ID: 22884125
[TBL] [Abstract][Full Text] [Related]
20. Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome.
Kramer JM; Holodick NE; Vizconde TC; Raman I; Yan M; Li QZ; Gaile DP; Rothstein TL
J Leukoc Biol; 2016 Feb; 99(2):321-31. PubMed ID: 26382297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
